Ch
Redefining Care for Incurable Diseases Through Next-Gen Delivery Tech
we are doing
Gene To The Future
2018

Founded In

Become China's leading high-tech biopharmaceutical companyand build a global multi-field drug research and development platform

The founder team includes top scientists in the field of gene therapy, industrial experts with a background in international pharmaceutical companies, and Anping toxicology experts with preclinical drug evaluation experience.



The advisory team includes authoritative experts in gene therapy, clinicians from top-tier tertiary hospitals, and executives of listed pharmaceutical companies.

Gene Editing
BD-VLP Platform

Gene Editing Transient Delivery Technology---BDgene realizes the safe and efficient delivery of CRISPR and other gene editing tools through the leading viroid BDmRNA delivery technology.

Gene Addition
BDlenti Platform

Leading lentiviral design and process platform---BDgene's advanced lentiviral vector delivery technology effectively improves the virus production and the infection efficiency of hematopoietic stem cells.

01

/ 02

Gene Addition BDlenti Platform

Next one

Gene Aditing BD-VLP Platform

Next one

Share With You

All News
logo
info@bdgene.cn

Email

Building 10, No.55 Bixi Road, Minhang District, Shanghai,China

ADD

open

close